While it’s not as well-known as, say, leukemia or melanoma, multiple myeloma is the second most common blood cancer in adults, according to the Cancer Research Institute. “Multiple myeloma is a cancer ...
A study carried out by a team of researchers from The Institute of Cancer Research, London, found that combining two types of ...
A combination of genetic tests for a "very complex" blood cancer could accurately predict if the disease is likely to return ...
18don MSN
From nosebleeds to bloating: 6 often overlooked early signs of cancer that should not be ignored
Cancer may at times start with mild symptoms that are not easy to notice or may be confused with less serious issues. Identifying them earlier is crucial as it may result in earlier diagnosis and ...
Scientists have identified a more accurate way of predicting which patients with multiple myeloma are likely to relapse early ...
Iberdomide combined with standard therapies showed a statistically significant improvement in minimal residual disease (MRD) negativity rates, compared with the control arm, in patients with relapsed ...
The U.S. Food and Drug Administration (FDA) has updated the safety labeling for Carvykti, the multiple myeloma therapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback